Trials / Unknown
UnknownNCT04648761
Individualized Titration of Biologics in Severe Asthma
OPTIMAL - Individualized Titration of Biologics in Severe Asthma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
OPTIMAL is a non-inferiority, open label randomized clinical trial thats investigates a titration algorithm for anti IL 5 biologics in severe asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OPTIMAL algorithm | The OPTIMAL algorithm titrates anti IL 5 treatment by addjusting the intervals between injections by FEV1, blood eosinophils and exacerbations. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-10-01
- Completion
- 2023-10-01
- First posted
- 2020-12-02
- Last updated
- 2023-01-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04648761. Inclusion in this directory is not an endorsement.